Halozyme Therapeutics launches 1.50% convertible senior notes due 2033
The company filed an indenture to offer 1.50% convertible senior notes, with a maturity date of September 22, 2033.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed